ResMed's (RMD) Q1 Earnings Beat Estimates, Margins Expand
Zacks Investment Research | Oct 24, 2019 11:23PM ET
ResMed Inc. (NYSE:RMD) announced first-quarter fiscal 2020 adjusted earnings per share (EPS) of 93 cents, up 14.8% year over year. The metric also beat the Zacks Consensus Estimate by 6.9%.
Reported EPS was 83 cents for the quarter under review, reflecting an increase of 13.7% from the year-ago period.
Revenues in the reported quarter increased 15.8% year over year (up 17% at constant exchange rate or CER) to $681.1 million. The figure surpassed the Zacks Consensus Estimate by 3.6%.
A Closer View of the Top Line
Geographically, excluding Software-as-a-Service, revenues in the United States, Canada and Latin America improved 13% over the prior-year period to $370.3 million,led by robust performance by its mask and device product portfolios.
Global revenues from Software as-a-Service in the quarter under consideration summed $86.9 million, representing an 83% jump year over year.
ResMed Inc. Price, Consensus and EPS Surprise
Original post
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.